- Webinar
- January 2022
- 90 Minutes
Global
- Webinar
- November 2021
- 90 Minutes
Global
- Training
- May 2021
- 2 Days
Global
From €1624EUR$1,699USD£1,381GBP
- Training
- March 2021
- 2 Days
Global
From €1815EUR$1,899USD£1,544GBP
- Training
- April 2020
- 2 Days
Global
From €1624EUR$1,699USD£1,381GBP
- Webinar
- September 2019
- 120 Minutes
Global
- Webinar
- May 2019
- 90 Minutes
Global
- Webinar
- September 2018
- 180 Minutes
Global
- Webinar
- June 2018
- 60 Minutes
Global
- Training
- 12 Hours
Global
€4300EUR$4,500USD£3,659GBP
- Webinar
- November 2022
- 360 Minutes
Global
From €569EUR$595USD£484GBP
- Webinar
- May 2022
- 240 Minutes
Global
From €473EUR$495USD£402GBP
- Webinar
- February 2022
- 240 Minutes
Global
From €473EUR$495USD£402GBP
- Webinar
- February 2021
- 180 Minutes
Global
From €325EUR$340USD£276GBP
- Webinar
- December 2020
- 90 Minutes
Global
From €182EUR$190USD£154GBP
- Webinar
- May 2019
- 120 Minutes
Global
- Webinar
- March 2019
- 120 Minutes
Global
- Webinar
- August 2018
- 90 Minutes
Global
From €182EUR$190USD£154GBP
- Webinar
- August 2018
- 60 Minutes
Global
- Book
- January 2020
- 592 Pages
Out of Specification Results (OOS) is a term used in the pharmaceutical manufacturing industry to describe results that do not meet the predetermined standards of quality. OOS results can be caused by a variety of factors, including incorrect raw materials, incorrect process parameters, or incorrect testing methods. OOS results can have a significant impact on the quality of the final product, and can lead to costly delays in production.
The OOS Results market is comprised of companies that provide services to help pharmaceutical manufacturers identify and address OOS results. These services include consulting, training, and software solutions to help manufacturers identify and address OOS results. Companies in this market include Parexel, IQVIA, and Charles River Laboratories. Show Less Read more